Neovastat—a novel antiangiogenic drug for cancer therapy
Colorectal cancer in 2003: old principles, new strategies
Pharmacokinetic study of docetaxel in intraoperative hyperthermic i.p. chemotherapy for ovarian cancer
Increasing-dose gemcitabine plus low-dose cisplatin in metastatic non-small cell lung cancer
Capecitabine treatment results in increased mean corpuscular volume of red blood cells in patients with advanced solid malignancies
Clinical pharmacology and pharmacogenetics of flavopiridol 1-h i.v. infusion in patients with refractory neoplasms
Feasibility and toxicity of CCNU therapy in elderly patients with glioblastoma multiforme
Biweekly bolus 5-fluorouracil and leucovorin plus oxaliplatin in pretreated patients with advanced colorectal cancer: a dose-finding study
Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants
Preclinical in vitro evaluation of hematotoxicity of the cisplatin–procaine complex DPR
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase–Akt/PKB survival pathway
Differential effects of the optical isomers of KR30031 on cardiotoxicity and on multidrug resistance reversal activity